Stay updated on MOST: Stroke Thrombolysis Clinical Trial
Sign up to get notified when there's something new on the MOST: Stroke Thrombolysis Clinical Trial page.

Latest updates to the MOST: Stroke Thrombolysis Clinical Trial page
- Check4 days agoChange DetectedResults have been posted for the MOST trial, and the study status/dates have been updated (including the last update and completion dates).SummaryDifference0.3%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedAdded a new prespecified subgroup analysis publication from the MOST Trial (thrombolysis alone vs with Argatroban/Eptifibatide) with full citation and author list. No deletions detected.SummaryDifference2%

- Check33 days agoChange DetectedRelease v3.2.0 includes a critical government-funding status notice and links for operating status, replacing the previous v3.1.0.SummaryDifference3%

- Check40 days agoChange DetectedUpdated to Revision v3.1.0 and removal of multiple drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs), indicating content pruning in the drug-safety area and a new version tag.SummaryDifference0.3%

- Check47 days agoChange DetectedMinor bibliographic formatting changes to a cited article; essentially no substantive content change.SummaryDifference0.0%

- Check54 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; the old revision label was removed. The 'Back to Top' element was also removed, which is a minor UI change.SummaryDifference0.2%

Stay in the know with updates to MOST: Stroke Thrombolysis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MOST: Stroke Thrombolysis Clinical Trial page.